<DOC>
	<DOCNO>NCT00000209</DOCNO>
	<brief_summary>The purpose study explore feasibility extend dose interval well maintain buprenorphine patient 48 72 hour , lead eventual 3 times/week dosing .</brief_summary>
	<brief_title>Buprenorphine Dosing Interval - 5</brief_title>
	<detailed_description />
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>M/F age 2150 . Opiate dependence accord DSMIV critera . Selfreported use within last 30 day . Agreeable condition study sign informed consent . Psychiatric disorder require medication therapy . History seizure . Pregnant and/or nursing woman . Dependence ETOH benzodiazepine sedativehynotics . Acute hepatitis . Other medical condition deem participation unsafe .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 1994</verification_date>
</DOC>